Lipid droplet–mitochondria contact sites as druggable spatial-pharmacology targets in respiratory disease: cross–cell-type mechanisms and translational strategies
Shuting Li, Rongrong Bai · 2026
Read Lipid droplet–mitochondria contact sites as druggable spatial-pharmacology targets in respiratory disease: cross–cell-type mechanisms and translational strategies by Shuting Li, Rongrong Bai (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13590267.txt.
Description
Shuting Li and Rongrong Bai mapped a drug target where fat meets power plants in two thousand twenty-six. Fat droplets and mitochondria touch at regulated sites. Those contacts now look measurable and druggable. Liver and muscle studies mapped the toolkit first. Lung disease has lagged despite deep lipid dependence. Surfactant making and fat handling define lung work.
The review builds a matrix across lung cell types. Evidence is graded direct, indirect, or borrowed. Scaffold proteins and tether molecules anchor the sites. Their shapes and switches behave like drug variables. Translation routes for lung therapy are laid out. Spatial pharmacology gains a respiratory beachhead.
Catalog record
| CREATOR | Shuting Li, Rongrong Bai |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 106 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |